Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants

Table 3

Assessment percentage of eyes with a change in macular edema and change in the number of hyperreflective foci at the end of the treatment period.

Group	Macular edema				Number of foci
	Dry	Decreased	Unchanged	Increased	Decreased	Increased
VEGF group	2/32 (6.25%)	22/32 (68.75%)	4/32 (12.5%)	4/32 (12.5%)	20/32 (62.5%)	12/32 (37.5%)
DEX group	8/19 (42%)	10/19 (53%)	1/19 (5%)	—	13/19 (68%)	6/19 (32%)